Romilda Cardin - Publications

Circulating microRNAs as biomarkers of disease activity and treatment response in Crohn's disease patients receiving infliximab or vedolizumab: a longitudinal cohort study.

Journal: Frontiers in medicine

Published: June 29, 2026

Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?

Journal: Expert review of gastroenterology & hepatology

Published: July 05, 2025

Differential target of oxidative damage in Helicobacter pylori-related and autoimmune atrophic gastritis: a single-center study.

Journal: Frontiers in medicine

Published: February 26, 2025

Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study.

Journal: Cancers

Published: February 20, 2025

Activation of the Contact System and Intrinsic Pathway in Peripheral and Portal Venous Circulations in Liver Cirrhosis.

Journal: Thrombosis and haemostasis

Published: December 24, 2024

Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 months.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 09, 2024

Crosstalk between MicroRNAs and Oxidative Stress in Coeliac Disease.

Journal: Inflammatory intestinal diseases

Published: November 01, 2023

HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 22, 2023

Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection.

Journal: Frontiers in immunology

Published: April 28, 2022

Validation of an LC-MS/MS method for the quantification IOA-289 in human plasma and its application in a first-in-human clinical trial.

Journal: Journal of pharmaceutical and biomedical analysis

Published: March 10, 2022

Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization.

Journal: Biomedicines

Published: June 30, 2021

Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?

Journal: Cancers

Published: April 16, 2021